Glaucoma is a common eye condition that affects millions of individuals worldwide, making it
the second-leading cause of blindness. Because glaucoma is associated with increased IOP …

Glaucoma is a neurodegenerative disease characterized by progressive loss of retinal
ganglion cells and their axons. Lowering of intraocular pressure (IOP) is currently the only …

Although challenges in medical treatment of glaucoma exist, particularly in patient
adherence, medical therapy remains the first line treatment for almost all glaucoma patients …

The first line treatment in the management of glaucoma is topical medical therapy. Many
patients with glaucoma require multiple medications for adequate intraocular pressure …

Fixed combinations of topical glaucoma medications : Current Opinion in Ophthalmology Fixed
combinations of topical glaucoma medications : Current Opinion in Ophthalmology Log in or …

Introduction Glaucoma is the leading cause of irreversible blindness worldwide. Medical
therapy is the main line of treatment of open-angle glaucoma (OAG) and ocular …

The use of any active pharmacological agent invariably is associated with unwanted
occurrences to which we give the name side effects or adverse effects. In some cases, these …

The aim of glaucoma therapy is to preserve visual function with minimal complications.[1]
Added to this is the need to ensure that quality of life is maintained. It is essential, therefore …

Introduction: Glaucoma is the second leading cause of blindness in the world and current
pharmacotherapies for glaucoma have remained relatively unchanged (with the exception of …

Glaucoma is a neurodegenerative disease characterized by retinal ganglion cell (RGC)
death and axonal loss. It remains a major cause of blindness worldwide. All current …